Early hospital readmission increases mortality in patients with ILD

Preventing early hospital readmission in patients with interstitial lung disease (ILD) may impact clinical course in these patients, according to a study that found that early readmission increased short-term and long-term mortality.

In this observational study, the clinical records of a cohort of 98 patients with ILD admitted to the respiratory ward were analyzed. Early readmission was defined as hospitalization within 30 days after the patient’s discharge.

Of the patients with ILD, 74 were discharged of which 15 were readmitted early. More patients who were early readmitted were current smokers (20% vs 2%). Early readmission was found to be independently associated with 90-day and 1-year mortality.

The authors concluded that further studies should be conducted to determine which factors contribute to early readmission.

Reference
Castillo D, Barril S, Rodrigo-Troyano A, et al. Early hospital readmission increases short and long-term mortality in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021021. doi: 10.36141/svdld.v38i2.10709. Epub 2021 Jun 28. PMID: 34316260; PMCID: PMC8288207.